India's Gene and Biotech Regulation Advances with Policies and Frameworks

India is advancing its gene and biotech frameworks to support safe and ethical development of gene-editing therapies such as CRISPR. The regulatory bodies CDSCO, ICMR, and DBT have introduced guidelines for gene therapy product development, while initiatives like the BioE3 Policy aim to enhance the country's biomanufacturing capabilities. Significant strides in gene therapy trials, biomanufacturing, and regulatory guidelines are paving the way for a resilient biotech ecosystem in India, ensuring affordable and accessible treatments.

Source: Original Link